These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 29520857)
21. Pityriasis rosea like drug rash - a need to identify the disease in childhood. Panda M; Patro N; Jena M; Dash M; Mishra S J Clin Diagn Res; 2014 Aug; 8(8):YD01-2. PubMed ID: 25302254 [TBL] [Abstract][Full Text] [Related]
22. Pityriasis rosea-like drug reaction to asenapine. Makdisi J; Amin B; Friedman A J Drugs Dermatol; 2013 Sep; 12(9):1050-1. PubMed ID: 24002155 [TBL] [Abstract][Full Text] [Related]
23. Pityriasis rosea-like eruption due to bismuth. Hanjani NM; Rencic A; Whitmore SE Cutis; 2006 Mar; 77(3):166-8. PubMed ID: 16610736 [TBL] [Abstract][Full Text] [Related]
24. The safety of ondansetron for nausea and vomiting of pregnancy: a prospective comparative study. Einarson A; Maltepe C; Navioz Y; Kennedy D; Tan MP; Koren G BJOG; 2004 Sep; 111(9):940-3. PubMed ID: 15327608 [TBL] [Abstract][Full Text] [Related]
25. Pityriasis rosea-like rash after messenger RNA COVID-19 vaccination: A case report and review of the literature. Buckley JE; Landis LN; Rapini RP JAAD Int; 2022 Jun; 7():164-168. PubMed ID: 35156062 [TBL] [Abstract][Full Text] [Related]
26. Intestinal obstruction in pregnancy by ondansetron. Cohen R; Shlomo M; Dil DN; Dinavitser N; Berkovitch M; Koren G Reprod Toxicol; 2014 Dec; 50():152-3. PubMed ID: 25461913 [TBL] [Abstract][Full Text] [Related]
27. Tongue and cheek: oral lesions in pityriasis rosea. Vidimos AT; Camisa C Cutis; 1992 Oct; 50(4):276-80. PubMed ID: 1424793 [TBL] [Abstract][Full Text] [Related]
28. Pityriasis rosea-like eruption associated with clozapine: a case report. Lai YW; Chou CY; Shen WW; Lu ML Gen Hosp Psychiatry; 2012; 34(6):703.e5-7. PubMed ID: 22516218 [TBL] [Abstract][Full Text] [Related]
29. Coronary vasospasm and atrial fibrillation associated with ondansetron therapy. Havrilla PL; Kane-Gill SL; Verrico MM; Seybert AL; Reis SE Ann Pharmacother; 2009 Mar; 43(3):532-6. PubMed ID: 19261954 [TBL] [Abstract][Full Text] [Related]
30. Pityriasis rosea-like cutaneous eruption as a possible dermatological manifestation after Oxford-AstraZeneca vaccine: Case report and brief literature review. Pedrazini MC; da Silva MH Dermatol Ther; 2021 Nov; 34(6):e15129. PubMed ID: 34533265 [TBL] [Abstract][Full Text] [Related]
31. One-year review of pityriasis rosea at the National Skin Centre, Singapore. Tay YK; Goh CL Ann Acad Med Singap; 1999 Nov; 28(6):829-31. PubMed ID: 10672397 [TBL] [Abstract][Full Text] [Related]
32. Geographic tonguelike presentation in a child with pityriasis rosea: Case report and review of oral manifestations of pityriasis rosea. Alzahrani NA; AlJasser MI Pediatr Dermatol; 2018 Mar; 35(2):e124-e127. PubMed ID: 29436009 [TBL] [Abstract][Full Text] [Related]
33. Atypical presentations of pityriasis rosea: case presentations. Chuh A; Zawar V; Lee A J Eur Acad Dermatol Venereol; 2005 Jan; 19(1):120-6. PubMed ID: 15649208 [TBL] [Abstract][Full Text] [Related]
34. Pityriasis rosea after administration of Pfizer-BioNTech COVID-19 vaccine. Cohen OG; Clark AK; Milbar H; Tarlow M Hum Vaccin Immunother; 2021 Nov; 17(11):4097-4098. PubMed ID: 34435935 [TBL] [Abstract][Full Text] [Related]
35. Pityriasis rosea-like eruption in a patient receiving omeprazole. Buckley C Br J Dermatol; 1996 Oct; 135(4):660-1. PubMed ID: 8915176 [No Abstract] [Full Text] [Related]
36. Ondansetron in pregnancy revisited: Assessment and pregnancy labelling by the European Medicines Agency (EMA) & Pharmacovigilance Risk Assessment Committee (PRAC). Damkier P; Kaplan YC; Shechtman S; Diav-Citrin O; Cassina M; Weber-Schoendorfer C Basic Clin Pharmacol Toxicol; 2021 Apr; 128(4):579-582. PubMed ID: 33275828 [TBL] [Abstract][Full Text] [Related]
37. Unilateral pityriasis rosea in a child: A rare clinical presentation. Oğrum A Turk J Pediatr; 2017; 59(2):214-216. PubMed ID: 29276879 [TBL] [Abstract][Full Text] [Related]